CX-2009, a CD166-directed probody drug conjugate (PDC): Results from the first-in-human study in patients (Pts) with advanced cancer including breast cancer (BC) Meeting Abstract
| Authors: | Boni, V.; Burris, H. A. 3rd; Liu, J. F.; Spira, A. I.; Arkenau, H. T.; Fidler, M. J.; Rosen, L. S.; Sweis, R. F.; Uboha, N. V.; Sanborn, R. E.; O'Neil, B.; Harding, J. J.; LoRusso, P.; Weise, A. M.; Garcia-Corbacho, J.; Victoria, I.; Frye, J. W.; Li, R.; Stroh, M.; Meric-Bernstam, F. |
| Abstract Title: | CX-2009, a CD166-directed probody drug conjugate (PDC): Results from the first-in-human study in patients (Pts) with advanced cancer including breast cancer (BC) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 12s |
| Language: | English |
| ACCESSION: | WOS:000560368300038 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.526 |
| Notes: | Meeting Abstract: 526 -- Source: Wos |
